Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Heart Failure 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Postoperative Complications 1Pheochromocytoma 1Pain, Postoperative 1Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Jaw Cysts 1Gastrointestinal Stromal Tumors 1Arrhythmias, Cardiac 1Agnosia 1

Interventions

Cyclophosphamide 192Methotrexate 106Cytarabine 86fludarabine phosphate 80Busulfan 71Tacrolimus 70Peripheral Blood Stem Cell Transplantation 69Mycophenolic Acid 69Whole-Body Irradiation 68Vincristine 67fludarabine 61Filgrastim 61Etoposide 59Dexamethasone 54Melphalan 52Radiotherapy 47Rituximab 46Cyclosporine 46Doxorubicin 38Antilymphocyte Serum 37Thiotepa 35Granulocyte Colony-Stimulating Factor 35Prednisone 34Mercaptopurine 34blinatumomab 33pegaspargase 27Methylprednisolone 27Daunorubicin 26Clofarabine 26Asparaginase 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Control Groups × Clear all
NCT07562568 2026-05-01

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

The First Affiliated Hospital of Soochow University

Phase 2 Not yet recruiting
160 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06816134 2026-04-23

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
48 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡